Scott Rocklage is a managing partner of 5 AM Ventures. He started with 5 AM Ventures in 2003 as a Venture Partner and later took on the role of managing partner. His 30+ years of experience in healthcare management has been a great asset to his current roles. Scott was responsible for the FDA approval of 3 new U.S. Drugs by the names of Cubicin®, Omniscan™, and Teslascan®. Scott has also helped numerous individuals enter into clinal trials for new and improved medications. Many of which have seen great success as a result.
Scott’s Education and Career Experience Before 5 AM Ventures
Before taking on his responsibilities at 5 AM Ventures Scott was the Chairman and CEO of Cubist Pharmaceuticals, the Board Chairman of Relypsa and Novira as well as the President and CEO of Nycomed Salutar. Scott studied at the University of California, the Massachusetts Institute of Technology and Berkeley. He has received a Bachelors degree and a Ph.D. in Chemistry. Scott is also an inventor who has been solely responsible or partially responsible for over 30 patents and has over 100 peer-reviewed publications to date.
Dedication and Passion That is Unparalleled
Scott’s dedication and passion for the healthcare industry are unparalleled. His dedication can be seen thoroughly through his extensive background as well as schooling. Whatever position Scott holds, you can be sure that he will approach it with full dedication and put forth the effort to ensure that it succeeds to the best of his ability. Learn more: http://www.rennovia.com/team/scott-m-rocklage/